Humira

Humira Biosimilars Not Gaining Traction Epitomizes Dysfunctional U.S. System
Humira Biosimilars Not Gaining Traction Epitomizes Dysfunctional U.S. System
Forbes
Humira
AbbVie
biosimilars
FDA
Flag link:
FDA Accepts sBLA for Interchangeability Designation for Humira biosimilars
FDA Accepts sBLA for Interchangeability Designation for Humira biosimilars
Dermatology Times
Samsung Bioepis
Organon
FDA
AbbVie
Humira
biosimilars
Flag link:
AbbVie Stock Dives As Aesthetics Sales Mar Its Third-Quarter Beat And Guidance Boost
AbbVie Stock Dives As Aesthetics Sales Mar Its Third-Quarter Beat And Guidance Boost
Investors Business Daily
AbbVie
earnings
aesthetics
Humira
biosimilars
Flag link:
FDA Decision On Interchangeable Exclusivity Allows Pfizer To Rival Boehringer On Adalimumab
FDA Decision On Interchangeable Exclusivity Allows Pfizer To Rival Boehringer On Adalimumab
Generics Bulletin
Pfizer
Humira
biosimilars
adalimumab
AbbVie
interchangeability
FDA
Flag link:
Boehringer Ingelheim embraces dual-pricing tactic with launch of unbranded Humira biosimilar
Boehringer Ingelheim embraces dual-pricing tactic with launch of unbranded Humira biosimilar
Fierce Pharma
Boehringer Ingelheim
Cyltezo
biosimilars
Humira
drug pricing
Flag link:
Boehringer launches 81% discounted biosimilar of AbbVie's Humira
Boehringer launches 81% discounted biosimilar of AbbVie's Humira
Reuters
Boehringer Ingelheim
biosimilars
AbbVie
Humira
unbranded biosimilars
Flag link:
Third Time Might Be a Charm for Alvotech as FDA Accepts BLA for Humira Biosimilar
Third Time Might Be a Charm for Alvotech as FDA Accepts BLA for Humira Biosimilar
BioSpace
Alvotech
FDA
biosimilars
AVT02
AbbVie
Humira
Flag link:
Alvotech gets new FDA review for Humira biosimilar
Alvotech gets new FDA review for Humira biosimilar
BioPharma Dive
Alvotech
FDA
Humira
biosimilars
Flag link:
Save billions or stick with Humira? Drug brokers steer Americans to the costly choice
Save billions or stick with Humira? Drug brokers steer Americans to the costly choice
Medical Marketing and Media
PBMs
biosimilars
Humira
Flag link:
AbbVie’s Humira to Take Hit from Biosimilars, Next-Gen Therapies: Report
AbbVie’s Humira to Take Hit from Biosimilars, Next-Gen Therapies: Report
BioSpace
AbbVie
Humira
biosimilars
Crohn's Disease
Flag link:
Amgen's hyped Humira biosimilar fritters away its exclusivity advantage
Amgen's hyped Humira biosimilar fritters away its exclusivity advantage
Fierce Pharma
Amgen
AbbVie
biosimilars
Humira
Flag link:
Despite big Q2 declines for Humira and Imbruvica, AbbVie still boosts earnings guidance
Despite big Q2 declines for Humira and Imbruvica, AbbVie still boosts earnings guidance
Fierce Pharma
AbbVie
earnings
Humira
biosimilars
Imbruvica
Flag link:
Biosimilar makers split strategies in bid to take on top-selling Humira
Biosimilar makers split strategies in bid to take on top-selling Humira
BioPharma Dive
biosimilars
Humira
AbbVie
rebates
drug pricing
Amgen
Celltrion
Novartis
Boehringer Ingelheim
Biocon
Fresenius
Sandoz
Organon
Coherus
Flag link:
Teva expands Alvotech collab with 2 more biosims, increased manufacturing oversight and a $40M investment
Teva expands Alvotech collab with 2 more biosims, increased manufacturing oversight and a $40M investment
Fierce Pharma
Teva Pharmaceutical
Alvotech
biosimilars
Humira
AbbVie
drug manufacturing
Flag link:
Four Crucial Questions about the Humira Biosimilar Price War
Four Crucial Questions about the Humira Biosimilar Price War
Drug Channels
AbbVie
Humira
biosimilars
Flag link:
7 companies are rolling out Humira biosimilars
7 companies are rolling out Humira biosimilars
Drugstore News
AbbVie
Humira
biosimilars
Boehringer Ingelheim
Organon
Samsung Bioepsis
Sandoz
Fresenius Kabi
Celltrion
Coherus Biosciences
Biocon
Flag link:
Mark Cuban's online pharmacy set to launch Humira biosimilar
Mark Cuban's online pharmacy set to launch Humira biosimilar
Reuters
biosimilars
Mark Cuban
Mark Cuban Cost Plus Drugs
AbbVie
Humira
Coherus Biosciences
Flag link:
Alvotech to raise cash after third FDA rejection for Humira biosimilar
Alvotech to raise cash after third FDA rejection for Humira biosimilar
BioPharma Dive
Alvotech
Teva Pharmaceutical
AbbVie
Humira
biosimilars
FDA
Flag link:
Coherus breached Humira patent settlement by striking deal with Mark Cuban's drug firm, AbbVie contends
Coherus breached Humira patent settlement by striking deal with Mark Cuban's drug firm, AbbVie contends
Fierce Pharma
AbbVie
Humira
biosimilars
Mark Cuban Cost Plus Drugs
Coherus Biosciences
Flag link:
Mark Cuban online pharmacy to offer AbbVie Humira biosimilar
Mark Cuban online pharmacy to offer AbbVie Humira biosimilar
Seeking Alpha
AbbVie
Mark Cuban
Humira
biosimilar
Coherus Biosciences
Mark Cuban Cost Plus Drugs
Yusimry
Flag link:

Pages